The treatment is now being applied to patients infected with covid-19 from when they enter the emergency room.
- Clodomiro Picado Research Institute photo -
Published Thursday, November 12, 2020
Treatment made in Costa Rica
against covid-19 advances
By the A.M. Costa Rica staff
The application of the treatment against covid-19 developed by scientists from the Clodomiro Picado Research Institute of the University of Costa Rica is advancing, Social Security reported.
According to the institute, the treatment is now being applied to patients infected with covid-19 from when they enter the emergency room.
This strategy is to apply the treatment shortly after having a positive result of the covid-19 diagnostic test when the patient is being treated in the emergency room.
However, since this treatment is still in a trial state, it is being applied only to patients in the moderate health condition category.
In October the treatment was applied to the first test group of 27 covid-19 patients.
According to Alfredo Sanabria-Castro, researcher of the Social Security researcher and Willem Bujan, researcher at the UCR, the analysis carried out will determine the results to scientifically indicate if there is a difference between the two types of treatment produced by the institute.
Both treatments were administered to covid-19 patients with a moderate or severe condition of sickness. Most of them with less than 10 days of symptoms, but all of them with two or more risk factors such as high blood pressure, diabetes, heart disease, asthma, morbid obesity and smoking. These health issues may increase the risk of developing a critical stage of infection.
According to Bujan, the preliminary analysis doesn't show which one of the two formulations are more effective. There is also no evidence of a difference in safety, which suggests adequate tolerability of both research products.
From Sept. 6- 18, the treatment was applied to 27 patients with covid-19. Of these 13 received a formula called "A" and 14 were treated with a formula called "B."
Of the 27 patients, 10 were women and 17 were men. The age range of the study group is between 31 to 77.
As of Oct. 1, the results of 16 patients were positive, they left the hospital and were able to continue treatment at home. Of these only one patient had to be hospitalized again, however, the reason for returning to the hospital was for other medical reasons unrelated to the study.
The treatment side effect more common was drowsiness which could be related to pre-medication, according to the researchers.
However, of the total number of patients, 13 presented complications in the development of the disease, for which some of them were given assisted mechanical ventilation.
Of these six died due to covid-19. These were patients with ages very close to 70, in addition to the presence of pre-existing health problems that compromised their body, specialists said.
A new trial group with covid-19 patients, according to specialists, are experimenting to find the optimal dose of treatment to effectively treat patients in different states of the virus.
Scientists' are on the brink of finding an effective treatment against covid-19.
On Wednesday, the Ministry of Health reported a continuous increase in new cases of infected people as well as deaths caused by the virus. The following are the statistics provided by the ministry:
1,202 new covid-19 cases, bringing the total to 44,746 active cases.
18,291 foreign-born people have been infected with a total of 119,768 cases since March, approximately 15.2% of the total cases. Of these, authorities confirmed the death of 32 foreign-born patients.
492 patients are being treated in public hospitals, where 197 patients are in ICUs in delicate health conditions (ages range from a 1-year-old to a 93-year-old). And 295 patients are in recovery rooms. Many of the remaining infected patients are quarantined in their homes.
73,509 coronavirus patients have fully recovered, which is a 61.4% recovery rate of the total cases since March.
1,513 deaths of people infected with covid-19, approximately 1.3% death rate of the total cases since March. Of these 573 women and 940 men. The ages range from a 9-year-old to a 101-year-old person.
Since October authorities stopped providing the number of people who have been ruled out and the number of medical covid-19 tests that have been made.
Readers can see the updated number of total patients in each district at the National Distance Education University on its Covid-19 Map.
According to the Center for Systems Science and Engineering, CSSE, at Johns Hopkins University, the pandemic has killed 1,283,510 people worldwide.
How should health authorities increase the application of the treatment against covid-19 to more patients? We would like to know your thoughts on this story. Send your comments to firstname.lastname@example.org